Bharat Biotech's intranasal booster dose to hit market in Feb
According to the company, the price of iNCOVACC will be Rs 900 for the private market and Rs 325 for supplies to...
NTAGI to discuss inclusion of Covovax in CoWIN portal
The National Technical Advisory Group on Immunisation (NTAGI) is likely to meet soon to discuss inclusion of...
DCGI recommends Covovax as heterologous booster dose
The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market...
Nasal vaccine iNCOVACC available for Rs 325 in govt hospitals
Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will be priced at...
Hetero's 'Nirmacom' first generic version of COVID-19 drug
Govt of India approves Bharat Biotech's nasal vaccine - iNCOVACC
Bharat Biotech's nasal vaccine - iNCOVACC has been approved by the Government of India and will be used as a...
Scientists globally come together to fight pathogens
iNCOVACC world's first intra-nasal vaccine to receive approval
DCGI approves '5-arms intranasal hetrologous booster dose'...
DCGI's SEC to hold discussion on "five arms" booster dose
DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in...
Antano & Harini successfully conclude 6-Day carnival
Bharat Biotech applies for market authorisation from DCGI
Copyright © aninews.in | All Rights Reserved.